BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 32778640)

  • 1. Silencing of Long Non-Coding RNA (LncRNA) Non-Coding RNA Activated by DNA Damage (NORAD) Inhibits Proliferation, Invasion, Migration, and Promotes Apoptosis of Glioma Cells via Downregulating the Expression of AKR1B1.
    Luo L; Chen C; He H; Cai M; Ling C
    Med Sci Monit; 2020 Jul; 26():e922659. PubMed ID: 32778640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway.
    Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro and in vivo study of the role of long non-coding RNA-HOST2 in the proliferation, migration, and invasion of human glioma cells.
    Wang Q; Zhuang ZW; Cheng YM; Ma JQ; Xu SY; Zhong CL; Zhang KM
    IUBMB Life; 2019 Jan; 71(1):93-104. PubMed ID: 30290058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of lncRNA-UCA1 inhibits cell viability and migration of human glioma cells by miR-193a-mediated downregulation of CDK6.
    Xin H; Liu N; Xu X; Zhang J; Li Y; Ma Y; Li G; Liang J
    J Cell Biochem; 2019 Sep; 120(9):15157-15169. PubMed ID: 31111564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myosin Heavy Chain 10 (MYH10) Gene Silencing Reduces Cell Migration and Invasion in the Glioma Cell Lines U251, T98G, and SHG44 by Inhibiting the Wnt/β-Catenin Pathway.
    Wang Y; Yang Q; Cheng Y; Gao M; Kuang L; Wang C
    Med Sci Monit; 2018 Dec; 24():9110-9119. PubMed ID: 30552850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of FPR2 gene silencing on the proliferation, migration and invasion of human glioma U87 cells].
    Liu L; Li X; Shi J; Li L; Wang J; Luo ZZ
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):659-666. PubMed ID: 30293389
    [No Abstract]   [Full Text] [Related]  

  • 7. Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR‑26a‑5p.
    Hu W; Zhao Y; Su L; Wu Z; Jiang W; Jiang X; Liu M
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34435652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2.
    Xu CH; Xiao LM; Liu Y; Chen LK; Zheng SY; Zeng EM; Li DH
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):241-252. PubMed ID: 30657566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of long non-coding RNA NORAD promotes invasion and migration in malignant melanoma via regulating the MIR-205-EGLN2 pathway.
    Chen Y; Cao K; Li J; Wang A; Sun L; Tang J; Xiong W; Zhou X; Chen X; Zhou J; Liu Y
    Cancer Med; 2019 Apr; 8(4):1744-1754. PubMed ID: 30843652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing long noncoding RNA LINC01138 inhibits aerobic glycolysis to reduce glioma cell proliferation by regulating the microRNA‑375/SP1 axis.
    Xu C; Yin H; Jiang X; Sun C
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34643249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway.
    Zhang L; Wang Y; Su H
    Neoplasma; 2020 Jul; 67(4):762-772. PubMed ID: 32726126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA NNT-AS1 promote glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis.
    Zheng D; Chen D; Lin F; Wang X; Lu L; Luo S; Chen J; Xu X
    Cell Cycle; 2020 Jul; 19(13):1621-1631. PubMed ID: 32420808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
    Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
    Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncNORAD interference inhibits tumor growth and lung cancer cell proliferation, invasion and migration by down-regulating CXCR4 to suppress RhoA/ROCK signaling pathway.
    Wu Y; Shen QW; Niu YX; Chen XY; Liu HW; Shen XY
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5446-5455. PubMed ID: 32495879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA GAS5 regulates the proliferation, migration, invasion and apoptosis of brain glioma cells through targeting GSTM3 expression. The effect of LncRNA GAS5 on glioma cells.
    Li G; Cai Y; Wang C; Huang M; Chen J
    J Neurooncol; 2019 Jul; 143(3):525-536. PubMed ID: 31172354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
    Zhang Y; Li Y
    Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown long non-coding RNA PEG10 inhibits proliferation, migration and invasion of glioma cell line U251 by regulating miR-506.
    Liang J; Liu N; Xin H
    Gen Physiol Biophys; 2019 Jul; 38(4):295-304. PubMed ID: 31241046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA MT1JP inhibits proliferation, invasion, and migration while promoting apoptosis of glioma cells through the activation of PTEN/Akt signaling pathway.
    Zhang Y; Sui R; Chen Y; Liang H; Shi J; Piao H
    J Cell Physiol; 2019 Nov; 234(11):19553-19564. PubMed ID: 31066040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing the long noncoding RNA NORAD inhibits gastric cancer cell proliferation and invasion by the RhoA/ROCK1 pathway.
    Yu SY; Peng H; Zhu Q; Wu YX; Wu F; Han CR; Yan B; Li Q; Xiang HG
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3760-3770. PubMed ID: 31115002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of LncRNA SNHG20 on proliferation and apoptosis of glioma cells through regulating the PTEN/PI3K/AKT signaling pathway.
    Guo LP; Zhang ZJ; Li RT; Li HY; Cui YQ
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):253-261. PubMed ID: 30657567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.